Oxford, UK, and Cambridge, MA, US, 3 August 2018 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces the publication
Continue reading »
mypharmacynews.com
Home ยป
Oxford, UK, and Cambridge, MA, US, 3 August 2018 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces the publication
Continue reading »